Lidovalor Medicated Transdermal Patch 14cm x 10cm contains Lidocaine 5% w/w, a local anesthetic indicated for the management of localized pain associated with conditions such as postherpetic neuralgia, musculoskeletal pain, and minor soft tissue injuries. The patch delivers a controlled amount of lidocaine through the skin directly to the affected area, providing targeted analgesia by stabilizing neuronal membranes and inhibiting the initiation and conduction of nerve impulses. This transdermal system offers prolonged pain relief with minimal systemic absorption, reducing the risk of systemic side effects commonly associated with oral analgesics. The 14cm x 10cm size ensures adequate coverage of the painful area, facilitating ease of application and patient compliance. Lidovalor patches are designed for single-use and should be applied to intact, non-irritated skin for up to 12 hours within a 24-hour period. Patients should avoid applying heat sources over the patch to prevent increased absorption and potential toxicity. Common adverse reactions include mild local skin irritation or erythema at the application site. Lidovalor is contraindicated in individuals with known hypersensitivity to lidocaine or other amide-type local anesthetics. Use with caution in patients with severe hepatic impairment.